3.19.6. summary evidence recommendations management posterior urethral valves. summary evidenceleposterior urethral valves one life-threatening congenital anomalies urinary tract.1bantenatal therapy could considered based ultrasound findings, fetal urine biochemistry, amniotic fluid level, chromosomal status.4serum creatinine nadir 0.85 mg/dl correlated poor prognosis.2aneonatal circumcision adjunct antibiotic prophylaxis puv patients significantly decreases risk developing febrile utis first two years life.1bearly pharmacological management oxybutynin may improve bladder function.1bdespite optimal treatment, 20% patients develop esrd.2arenal transplantation patients safe effective, bladder function managed.3 recommendationsstrength ratingdrain bladder new-borns suspected diagnosis infravesical obstruction place antibiotic prophylaxisstrongperform voiding cystourethrography (vcug) patients diagnosis posterior urethral valves (puv) suspected.strongattempt endoscopic valve ablation bladder drainage stabilisation child.weakconsider neonatal circumcision adjunct antibiotic prophylaxis decrease risk urinary tract infection puv, especially presence high grade vesicoureteric reflux.strongoffer prolonged urinary diversion (suprapubic/transurethral) bladder drainage child small valve ablation.stronguse serum creatinine nadir prognostic marker.strongassess split renal function dimercaptosuccinic acid (dmsa) scan mercaptoacetyltriglycine (mag3) clearance.strongconsider high urinary diversion bladder drainage insufficient drain upper urinary tract, absence clinico-biochemical improvement.strongmonitor manage bladder renal function lifelong.strong